Smith & Wesson Brands (SWBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for September 15, 2025, to be held virtually; record date is July 25, 2025.
Key proposals: election of seven directors, advisory vote on executive compensation, and ratification of KPMG LLP as auditor for fiscal 2026.
Board recommends voting FOR all proposals.
Fiscal 2025 accomplishments include $48.6M returned to shareholders and $21.6M in capital expenditures.
Voting matters and shareholder proposals
Shareholders will vote on director elections, executive compensation (say-on-pay), and auditor ratification.
Proxy access allows groups of up to 20 shareholders owning 3%+ for 3 years to nominate directors.
Shareholders owning 25%+ of shares can call special meetings.
Proposals for the 2026 meeting must be submitted by April 7, 2026.
Board of directors and corporate governance
Board consists of seven members; six are independent.
More than 70% of directors joined since 2018; annual elections and majority voting standard.
Four standing committees: Audit, Compensation, NCG, and Sustainability, all comprised of independent directors.
Board skills matrix includes executive, financial, risk management, manufacturing, sustainability, and regulated industry experience.
Directors may not serve on more than three other public company boards.
Latest events from Smith & Wesson Brands
- Q3 net sales up 17.1% to $135.7M, with higher margins and strong Q4 outlook.SWBI
Q3 20265 Mar 2026 - Double-digit growth in revenue and net income, with 2025 outlook for continued gains and higher dividends.SWBI
Q4 20243 Feb 2026 - Q1 sales fell 22.7%, but new products and margin gains support a positive full-year outlook.SWBI
Q1 202522 Jan 2026 - Board re-elections, executive pay approval, and strong financial growth highlighted the meeting.SWBI
AGM 202420 Jan 2026 - Q2 sales up 3.8% to $129.7M, but guidance cut as inflation softens demand and margins.SWBI
Q2 202511 Jan 2026 - Q3 sales fell 15.7% as new products drove 41% of revenue, but margins and sales remain pressured.SWBI
Q3 202527 Dec 2025 - Q2 sales dipped 3.9% but cash flow and new product momentum support a strong Q3 outlook.SWBI
Q2 20267 Dec 2025 - Director elections, say-on-pay, and a human rights proposal headline a governance-focused agenda.SWBI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SWBI
Proxy Filing1 Dec 2025